Overview

Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Cystathionine beta-synthase deficiency is an inherited disease that results in elevation of a substance called homocysteine (Hcy) in blood and urine. Individuals with this disorder have a very high risk for developing blood clots and are at risk for developing eye and bone abnormalities. Current treatments are generally difficult to follow and can fail. Development of additional therapies has been limited by lack of understanding of how the disease works. The purpose of this study is to see if oxidative stress and inflammation are involved in the disease process and if short-term supplementation with taurine is an effective treatment. Funding source: FDA.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Colorado, Denver